Sinovac Biotech Ltd Capital Reinvestment Ratio
Sinovac Biotech Ltd capital reinvestment ratio. Sinovac Biotech Ltd (SVA) has a Capital Reinvestment Ratio of 0.36x as of December 2023, meaning it reinvests 0% of its operating cash flow ($146.01 Million) in capital expenditures ($52.75 Million). Check Sinovac Biotech Ltd (SVA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sinovac Biotech Ltd (2007–2023)
Capital reinvestment ratio of Sinovac Biotech Ltd from 2007 to 2023. This chart tracks Sinovac Biotech Ltd's Capital Reinvestment Ratio across 12 annual periods. Also explore SVA net asset momentum to track the company's year-over-year net asset growth rate.
Sinovac Biotech Ltd Capital Reinvestment Ratio by Year (2007–2023)
Sinovac Biotech Ltd capital reinvestment ratio by year from 2007 to 2023. For the full cash flow conversion analysis, see SVA cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.37x | $106.02 Million | $145.69 Million | ▲ +2830.3% |
| 2021 | 0.05x | $15.35 Billion | $719.98 Million | ▼ -82.4% |
| 2020 | 0.27x | $479.31 Million | $127.65 Million | ▼ -2.1% |
| 2019 | 0.27x | $39.07 Million | $10.63 Million | ▼ -61.5% |
| 2018 | 0.71x | $7.94 Million | $5.61 Million | ▲ +254.4% |
| 2017 | 0.20x | $59.76 Million | $11.91 Million | ▼ -84.2% |
| 2015 | 1.26x | $4.21 Million | $5.30 Million | ▲ +36.7% |
| 2013 | 0.92x | $5.58 Million | $5.13 Million | ▼ -17.0% |
| 2011 | 1.11x | $13.94 Million | $15.46 Million | ▲ +1142.9% |
| 2009 | 0.09x | $48.41 Million | $4.32 Million | ▼ -76.4% |
| 2008 | 0.38x | $10.50 Million | $3.98 Million | ▼ -33.8% |
| 2007 | 0.57x | $4.32 Million | $2.47 Million | — |